Metabolism of 14 C-propionate and methylmalonate was severely curtailed in fibroblasts cultured from an infant with massive transient hyperammonemia (1370 ^g/100 ml), severe metabolic acidosis, and excretion of large amounts of methylmalonic acid (580 mg at 24°). Metabolism of succinate was normal.
Introduction
Excretion of massive amounts of methylmalonic acid in urine in the absence of vitamin B 12 deficiency has been described in disease states of genetic origin in infants and children. This abnormality has been ascribed to a deficiency of methylmalonyl coenzyme A mutase (EC 5.4.99.2) activity in the patients reported to date either because of a defect of the apoenzyme or a defective synthesis of the specific vitamin B 12 cofactor required by this enzyme. Clinically, these two forms of methylmalonic aciduria are distinguishable since the latter responds to the administration of pharmacologic doses of vitamin B 12 [13] .
Although it has not been observed in patients reported previously, excessive excretion of methylmalonic acid might also occur with a defect of methylmalonyl-CoA racemase (EC 5.1.99.1), the enzyme which catalyzes the step before the mutase reaction.
In the normal state in the metabolism of propionate to succinate, the enzyme, propionyl-CoA carboxylase, carboxylates propionyl-CoA to methylmalonyl-CoA. Inasmuch as methylmalonyl-CoA contains an asymmet- ric carbon, two isomeric forms of this compound are possible. The steric form resulting from the carboxylation of propionyl-CoA, designated form a, must first be converted to its optical enantiomorph by methylmalonyl-CoA racemase, before it can be converted to succinate by the isomerase [10] . Defective racemase activity could therefore result in accumulation of methylmalonyl-CoA (form a) which would result in the increased excretion of methylmalonic acid after nonenzymatic cleavage of the thioester from the acid. (Fig. 
Case History
A newborn infant believed to have such a deficiency in racemase activity has been observed recently. This full term male infant seemed to be normal until 2.5 days of age when he developed progressively severe metabolic acidosis, obtundation, and coma. Hyperammonemia was noted and treated with four exchange transfusions and other supportive measures. Despite these therapeutic attempts he failed to rally and on the 11th day succumbed to overwhelming Klebsiella sepsis. Details of the clinical course and other studies of this infant will be presented elsewhere [7] .
Laboratory Methods
Ammonia was determined by a microdiffusion method [3] .
Methylmalonic acid in blood, urine, and tissues was measured by the following modification of the method of Giorgio and Plaut [5] . The column was washed with 50 ml H 2 O and 15 ml 0.5 N HC1 before elution of methylmalonic acid with 2 X 15 ml 0.5 N HC1. Then samples were cooled in ice immediately after heating before the addition of alkali.
Skin biopsies were obtained from the patient, his parents, and two normal infants (circumcision). Explants were grown in Dulbecco's modified Eagle Medium or nutrient mixture F lo [15] which contained 10% fetal calf serum and 100 units penicillin/ml and 100 mg streptomycin/ml. Vitamin B 12 was not detectable in the Eagle's Medium and was over 5,000 pg/ml in medium F 10 [16] .
Fibroblasts were grown to confluence in 60 mm diameter disposable Petrie dishes, harvested with 0.05% trypsin which contained 200 mg ethylenediaminetetracetic acid/1000 ml, washed twice with phosphate-buffered saline, and centrifuged at 100 X g for 1.5 min at room temperature after each wash. Cell counts were obtained immediately before each experiment. Fibroblast homogenates were prepared by rapid alternation of freezing and thawing at 37° five times in 1-2 volumes phosphate-buffered saline.
For study of propionate metabolism, cells or homogenates were incubated in 1 ml Krebs phosphate buffer, pH 7.4, containing Na propionate-3- C acid, 0.5 ^Ci (0.08 HIM) at 37°. Cells or homogenates were incubated 3 hours for the propionate and methylmalonate and 2 hours for the succinate experiments. (In the methylmalonate experiments addition of 2.5 to 12 /xg DBCC did not cause a significant increase in 14 CO 2 evolved.) Unlabeled substrate was added and CO 2 was released with 6 N H 2 -SO 4 . The 14 CO 2 evolved was collected in 20% KOH, added to Liquiflor before radioactivity was determined by scintillation spectrometry [17] .
Liver obtained 1 hr after death was kept frozen at -80° until analysis. Control livers for racemase, mutase, and urea cycle enzymes were obtained from a neonate who died of hyaline membrane disease (several hours after death), an infant with an ornithine carbamyl transferase (OTC) deficiency (1 hr postmortem), a 3-year-old child with cystinosis (12 hr postmortem), and a neonate who died of aortic atresia (12 hr postmor-tem). Liver was homogenized in 2 volumes 0.25 M sucrose in the dark. The supernatant obtained after centrifuging at 5,000 X g for 1 hr at 4° was used.
For the methylmalonyl-CoA studies, liver and fibroblast homogenates were incubated for 20 min with 20 [tM Tris-sulfate buffer, pH 7.3, which contained 3 Hmethylmalonyl-CoA, 0.2 ^Ci; DBCC, 12 M g/1.4-2.7 mg protein. Alkaline hydrolysis, extraction, and separation of methylmalonic and succinic acids were performed as described by Cardinale et al. [2] . The acids were eluted with 0.1 N HC1 and added to Aquasol; the radioactivity was then measured by scintillation spectrometry.
Mitochondria were isolated from liver tissue according to the method of Hogeboom [6] except that suspension and sedimentation of mitochondria were performed once. The sediment was resuspended in 0.25 M sucrose and subjected to rapid, alternating freeze-thawing 10 times. Homogenates containing 0.9-1.6 mg protein were added to 7 / xM unlabeled synthetic, racemic methylmalonyl-CoA, 50 pi water, and 0.6 mCi 3 H 2 O and were incubated at 30° for 25 min. A sucrose blank without protein was also centrifuged to measure spontaneous racemization. Salt-free neutralized hydroxylamine, 1 HIM [8] was added and the mixture was allowed to stand at room temperature for 30 min. Subsequent procedures were carried out at 4° according to the method of Mazumder et al. [11] except that the supernatant was made 1.0 N with respect to NH 4 OH before application to a column of Dowex 1-X10 in the chloride form. The eluted methylmalonylhydroxamic acid was dried, taken up in water, and added to Aquasol [18] before a reading was taken by scintillation spectrometer. All values were corrected for spontaneous racemization by subtraction of the sucrose blank value. Total protein was determined by the Lowry method [9] . DL-2-Methyl-3 H-malonyl-CoA was synthesized from DL-2-methyl-8 H-malonic acid and CoA according to the method of Trams and Brady [14] .
The DBCC content was assayed by the dioldehydrase method by Dr. Robert Abeles, Brandeis University, Waltham, Mass. [1] .
Results
Large amounts of methylmalonic acid were found in all samples of urine tested: 580 mg at 24° compared with 5.8 ± 4.2 mg at 24° in normal subjects [5] . The methylmalonic acid concentration of a pooled serum specimen (collected before the initial blood exchange transfusion) was high also: 28.8 mg/100 ml compared with 0.75 mg/100 ml in a control subject. In a postmortem specimen from liver obtained 1 hr after death, the concentration of free and total methylmalonic acid was 0.63 and 2.17 mg/g wet weight, respectively, compared with 0.17 and 1.46 mg/g wet weight in a control subject.
The content of DBCC in liver was within normal limits (70 and 50 mp.g/g wet weight on two separate assays: normal value, 67-240 m^,g/g wet weight) [1] .
The metabolism of 14 C-labeled propionate and methylmalonate was severely curtailed in fibroblasts cultured from the patient, whereas metabolism of succinate was normal (Table I) .
Metabolism of these substrates by liver homogenates are similarly reflected in Table II. Fibroblasts and homogenates from liver metabolized added tritiated racemic methylmalonyl-CoA half as well as control samples (Table III) .
Mitochondrial homogenates from liver incorporated insignificant amounts of tritium when they were incubated with synthesized unlabeled methylmalonyl-CoA and tritiated water, in contrast to normal control homogenates (Table IV) .
Ornithine carbamyl transferase activity, argininosuccinate synthetase (AS) activity, argininosuccinate lyase (AL) activity, and arginase activity were 15-30% of normal but not rate limiting and carbamyl phosphate synthetase (CPS) activity was within the range for normal adults (Table V) .
Discussion
Results of 14 C-propionate, methylmalonate, and succinate metabolism of cultured fibroblasts and liver homogenates indicate the presence of a block in the conversion of methylmalonate to succinate which could be due to either defective mutase or racemase activity, or, remotely, to a combination defect of the two enzymes.
Deficiency of mutase activity can result either from an apoenzyme defect or from subnormal concentration of intracellular cofactor (which can, in turn, be due to defective cofactor metabolism or to diminished transport of the cofactor or appropriate B 12 precursor).
Problems of transport and metabolism of vitamin B 12 were eliminated by incorporating into our methods the following findings: metabolism of methylmalonate by homogenates of liver and intact or homogenized fibroblasts was not corrected by the addition of excessive amounts of the cofactor, 5'-deoxyadenosylcobalamin. Mutase deficiency was eliminated by demonstration of the ability of homogenates of liver and fibroblasts to metabolize tritiated DL-methylmalonyl-CoA (Table  III) . Chemically synthesized methylmalonyl-CoA is approximately a 50/50 mixture of forms a and b [11] . In the liver homogenate studies, the amount of racemic methylmalonyl-CoA converted to succinate was approximately half that of the control sample (Table  III) . Homogenates of fibroblasts converted somewhat more DL-methylmalonyl-CoA to succinate. (The reason for this augmented activity in fibroblasts has not yet been clarified but studies are currently in progress to explore this.)
The mechanism of racemization has been shown to occur by ionization and shift of the a-hydrogen atom [4] . Mazumder et al. [11] first observed the incorporation of tritium from 3 H 2 O into methylmalonyl-CoA during racemization. The uptake of the proton during metabolism of synthetic methylmalonyl-CoA can be readily demonstrated with homogenates of control liver (Table IV) . The uptake of tritium with mitochondrial homogenate from liver of the patient was insignificant (Table IV) .
In view of the hyperammonemia of the patient, enzymes of the urea cycle were measured. The low OCT, AS, AL, and arginase activity may be due to the poor Methylmalonyl-CoA racemase defect 879 intake of protein and high intake of glucose by the infant. None of the enzyme activities was rate limiting.
Theoretically, these findings could result from a combined lesion involving the racemase enzyme and a partial defect of the mutase. Such a combination would be difficult to imagine since partial defects (heterozygotes for the mutase defect) are not known to accumulate methylmalonic acid to any significant degree.
These findings support the diagnosis of a deficiency of methylmalonyl-CoA racemase and indicate that this new disorder should be considered in the differential diagnosis of patients with methylmalonic aciduria which is unresponsive to vitamin B 12 .
Summary
A neonate with hyperammonemia, acidosis, and coma was found to have methylmalonic aciduria and defective propionate to succinate metabolism. The metabolic defect resulted from impaired ability to convert methylmalonyl-CoA (form a) to its optical isomer, methylmalonyl-CoA (form b) because of a deficiency of methylmalonyl-CoA racemase activity.
